Autoimmune diabetes is characterized by an inflammatory reaction in and around pancreatic islets, followed by selective destruction of beta-cells. The broad goals of this research are to elucidate the cellular mechanisms associated with pancreatic beta-cell destruction and identify mechanisms by which beta-cells protect themselves against cytokine- and free radical-mediated damage. We have shown that nitric oxide mediates the inhibitory actions of interleukin-1 (IL-1) and interferon-gamma (IFN-gamma) on beta-cell function. Nitric oxide also activates a """"""""recovery"""""""" pathway that protects beta-cells from cytokine-mediated damage. It is this delicate balance between the toxic and protective actions of nitric oxide that may ultimately determine the susceptibility of beta-cells to cytokine-mediated damage. This proposal focuses on elucidating the cellular pathways of beta-cell destruction and recovery from cytokine-mediated damage. There are three specific aims. 1. To elucidate the biochemical mechanisms by which resident macrophage activation and proinflammatory cytokine release in islets mediates beta-cell damage. Experiments proposed will use a transgenic approach to determine the role of the IL-1a converting enzyme (ICE), the IL-1 receptor, and IL-1 receptor signaling components in mediating beta- cell damage stimulated by the local production of IL-1 by macrophages in the microenvironment of the islet. 2. To test the hypothesis that nitric oxide and peroxisome proliferator-activated receptor (PPAR)-gamma, agonists activate a pathway(s) that protects beta-cells from cytokine-mediated damage. Proposed experiments will examine the mechanisms by which nitric oxide and PPAR-gamma agonists prevent cytokine-mediated beta-cell damage. 3. To use expression profiling to identify candidate genes with altered expression under conditions associated with beta-cell recovery from cytokine-mediated damage. Once identified, these genes or gene products will be expressed or transduced into beta-cells to determine the mechanisms of protection from cytokine-mediated damage. A number of biochemical, molecular biological, immunological, histochemical, and transgenic techniques will be utilized to investigate the cellular pathways through which nitric oxide mediates beta-cell destruction and the pathways that participate in the protection of beta-cells from cytokine-mediated damage. It is hoped that insights into the mechanisms of cytokine-mediated damage and protection from this damage gained from these studies will influence the design of therapeutic strategies aimed at the prevention or treatment of this debilitating disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052194-10
Application #
7216431
Study Section
Metabolism Study Section (MET)
Program Officer
Spain, Lisa M
Project Start
1998-01-01
Project End
2007-08-31
Budget Start
2007-05-01
Budget End
2007-08-31
Support Year
10
Fiscal Year
2007
Total Cost
$84,210
Indirect Cost
Name
Saint Louis University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
050220722
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Baldwin, Aaron C; Naatz, Aaron; Bohnsack, Richard N et al. (2018) Cation-Independent Mannose 6-Phosphate Receptor Deficiency Enhances ?-Cell Susceptibility to Palmitate. Mol Cell Biol 38:
Kropp, Erin M; Broniowska, Katarzyna A; Waas, Matthew et al. (2017) Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores. Stem Cells Transl Med 6:1191-1201
Schwab, Andrew J; Sison, Samantha L; Meade, Michael R et al. (2017) Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons. Stem Cell Reports 9:1839-1852
Hye Khan, Md Abdul; Hwang, Sung Hee; Sharma, Amit et al. (2016) A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat 125:40-7
Oleson, Bryndon J; Broniowska, Katarzyna A; Naatz, Aaron et al. (2016) Nitric Oxide Suppresses ?-Cell Apoptosis by Inhibiting the DNA Damage Response. Mol Cell Biol 36:2067-77
Samson, Willis K; Stein, Lauren M; Elrick, Mollisa et al. (2016) Hypoglycemia unawareness prevention: Targeting glucagon production. Physiol Behav 162:147-50
Elrick, Mollisa M; Samson, Willis K; Corbett, John A et al. (2016) Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic ?-cells. Am J Physiol Regul Integr Comp Physiol 310:R143-55
Shaheen, Zachary R; Corbett, John A (2015) Macrophage Expression of Inflammatory Genes in Response to EMCV Infection. Biomolecules 5:1938-54
Broniowska, Katarzyna A; Mathews, Clayton E; Corbett, John A (2015) Reply to Gurgul-Convey and Lenzen: Cytokines, nitric oxide, and ?-cells. J Biol Chem 290:10571
Shaheen, Zachary R; Naatz, Aaron; Corbett, John A (2015) CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection. J Immunol 195:4406-14

Showing the most recent 10 out of 71 publications